Clinical audit: virological and immunological response to combination antiretroviral therapy in HIV patients at a Sydney sexual health clinic

Keywords

Calculator, Drag, Drop (telecommunication), Drag coefficient, Mechanics

References

• Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.Daniel P. Bunting — 2004
• Incidence and Predictors of Virologic Failure of Antiretroviral Triple-Drug Therapy in a Community-Based CohortDaniel H. Paris, Bruno Ledergerber, Rainer Weber — 1999
• Modeling the Time Course of CD4 T-Lymphocyte Counts According to the Level of Virologic Rebound in HIV-1–Infected Patients on Highly Active Antiretroviral TherapyIsabelle Kousignian, Sophie Abgrall, Xavier Duval — 2003
• Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.Matthias Egger, Margaret May, Geneviève Chêne — 2002
• Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremiaSteven G. Deeks, Jason D. Barbour, Robert M. Grant — 2002
• Discordant Responses to Potent Antiretroviral Treatment in Previously Naive HIV-1-Infected Adults Initiating Treatment in Resource-Constrained Countries: The Antiretroviral Therapy in Low-Income Countries (ART-LINC) CollaborationSuely Tuboi, Martin W. G. Brinkhof, Matthias Egger — 2007
• Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study.Roger Paredes — 2000
• Virologic, Immunologic, and Clinical Response to Highly Active Antiretroviral Therapy: the Gender Issue RevisitedAntonia L. Moore, Ole Kirk, Anne M. Johnson — 2003
• Do viral load and CD8 cell count at initiation of tritherapy influence the increase of CD4 T‐cell count?Olivia Keïta-Perse, Pierre‐Marie Roger, Christian Pradier — 1998
• Virological response to protease inhibitor therapy in an HIV clinic cohort.Schlomo Staszewski, Veronica Miller, Caroline Sabin — 1999
• Comparison of Virologic, Immunologic, and Clinical Response to Five Different Initial Protease Inhibitor‐Containing and Nevirapine‐Containing RegimensPhilippa Easterbrook, Roger Newson, Natalie Ives — 2001
• Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitorSophie Grabar, Christian Pradier, Emmanuelle Le Corfec — 2000
• Predictors of optimal virological response to potent antiretroviral therapy.William G. Powderly, Michael S. Saag, Sharon Chapman — 1999
• An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adultsJohn Bartlett, Michael Fath, Ralph DeMasi — 2006
• Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy Are Associated With Increased Mortality and Poor Adherence to TherapyDavid Moore, Robert S. Hogg, Benita Yip — 2005
• CD4 Cell Count Response to Nonnucleoside Reverse Transcriptase Inhibitor‐or Protease Inhibitor‐Based Highly Active Antiretroviral Therapy in an Observational Cohort StudyEvan Wood, Robert S. Hogg, Benita Yip — 2003
• Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosineJan Gerstoft, Ole Kirk, Niels Obel — 2003
• Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitorAmanda Mocroft, M. John Gill, William Davidson — 1998
• Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression.Fernando Dronda, Santiago Moreno, Ana Moreno — 2002
• Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA studyÉric Florence, Jens Lundgren, Christa Dreezen — 2003

Cited by

• Demographic and hematological factors associated with discordant immunologic response to antiretroviral therapy in an African cohortBatanayi Muzah — 2012
• THE INFLUENCE OF MENTAL ILLNESS ON PRESCRIBING PRACTICES OF ANTI- RETROVIRALS (ART)Janice Buckley — 2015
• Response to First-Line Antiretroviral Therapy Among PLHIV from a High-Risk, Low-Prevalence SettingSM Rashed Ul Islam, Munira Jahan, Afzalun Nessa — 2019
• Cohort analysis of clinical and treatment outcomes Integrated surveillance of HIV care in low-income and middle-income countries2011

Related papers

• The Xmath CalculatorOdd Bringslid — 2006